Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Athira Pharma, Inc. (ATHA) had Return on Tangible Equity of -24.49% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-9.14M |
|
-- |
|
-- |
|
$9.54M |
|
$-9.54M |
|
$0.39M |
|
$-9.14M |
|
$-9.14M |
|
$-9.14M |
|
$-9.14M |
|
$-9.14M |
|
$-9.14M |
|
$-9.54M |
|
$-9.36M |
|
39.04M |
|
39.04M |
|
$-0.23 |
|
$-0.23 |
|
| Balance Sheet Financials | |
$39.85M |
|
$2.20M |
|
$3.66M |
|
$43.51M |
|
$5.49M |
|
-- |
|
$0.69M |
|
$6.18M |
|
$37.33M |
|
$37.33M |
|
$37.33M |
|
39.04M |
|
| Cash Flow Statement Financials | |
$-14.66M |
|
$-7.35M |
|
-- |
|
$49.07M |
|
$27.05M |
|
$-22.02M |
|
$1.64M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.26 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-14.66M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-24.49% |
|
|
Return on Tangible Equity |
-24.49% |
-21.01% |
|
-24.49% |
|
$0.96 |
|
$-0.38 |
|
$-0.38 |
|